Inhibition of Tfam, due to hypermethylation, exacerbated the glycolysis rate and mitochondrial bioenergetics metabolism and subsequently inhibition of osteogenesis and bone formation, which caused obesity-induced metabolic osteoporosis. Here, TFAM is linked to obesity due to melanocortin 4 receptor deficiency.